Literature DB >> 10569189

Attenuation of sugar cataract by ethyl pyruvate.

P S Devamanoharan1, M Henein, A H Ali, S D Varma.   

Abstract

Studies describe an attenuation of sugar cataract formation by topical administration of ethyl pyruvate. Cataract formation was induced by feeding young rats a 30% galactose diet. Mature cataracts appeared in about thirty days. Instillation of the eye drops containing 5% ethyl pyruvate decelerated the process significantly. Biochemically, the effect was reflected by lowering in the contents of dulcitol and glycated proteins. The ATP levels were also higher in comparison to the placebo treated group. The effects are hence attributable to the effect of pyruvate in inhibiting dulcitol synthesis and protein glycation, in addition to its antioxidant properties and metabolic support. The use of esterified pyruvate instead of the unesterified pyruvate was preferred because of its greater penetration through the cornea and consequently a higher concentration attained in the aqueous humor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569189     DOI: 10.1023/a:1007055503748

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Galactosemia and its relation to Laennec's cirrhosis; review of the literature and presentation of six additional cases.

Authors:  E H TOWNSEND; H H MASON; P S STRONG
Journal:  Pediatrics       Date:  1951-06       Impact factor: 7.124

2.  Fructose induced deactivation of glucose-6-phosphate dehydrogenase activity and its prevention by pyruvate: implications in cataract prevention.

Authors:  W Zhao; P S Devamanoharan; S D Varma
Journal:  Free Radic Res       Date:  1998-10

Review 3.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

Review 4.  Relations among aging, antioxidant status, and cataract.

Authors:  A Taylor; P F Jacques; E M Epstein
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

5.  Sulfur oxidation in selected human cortical cataracts and nuclear cataracts.

Authors:  M H Garner; A Spector
Journal:  Exp Eye Res       Date:  1980-09       Impact factor: 3.467

6.  Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts.

Authors:  M O Creighton; W M Ross; P J Stewart-DeHaan; M Sanwal; J R Trevithick
Journal:  Exp Eye Res       Date:  1985-02       Impact factor: 3.467

7.  Diabetic cataracts and flavonoids.

Authors:  S D Varma; A Mizuno; J H Kinoshita
Journal:  Science       Date:  1977-01-14       Impact factor: 47.728

8.  Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats.

Authors:  R E Perry; M S Swamy; E C Abraham
Journal:  Exp Eye Res       Date:  1987-02       Impact factor: 3.467

9.  Serum carotenoids and tocopherols and severity of nuclear and cortical opacities.

Authors:  J A Mares-Perlman; W E Brady; B E Klein; R Klein; M Palta; P Bowen; M Stacewicz-Sapuntzakis
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-02       Impact factor: 4.799

10.  Diabetic cataract formation: potential role of glycosylation of lens crystallins.

Authors:  V J Stevens; C A Rouzer; V M Monnier; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

View more
  10 in total

1.  Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms.

Authors:  Hongxia Shen; Xiaoming Hu; Can Liu; Suping Wang; Wenting Zhang; Hui Gao; R Anne Stetler; Yanqin Gao; Jun Chen
Journal:  Neurobiol Dis       Date:  2009-12-21       Impact factor: 5.996

2.  Preventive effects of ethyl pyruvate on endotoxin-induced uveitis in rats.

Authors:  Nilesh M Kalariya; Aramati B M Reddy; Naseem H Ansari; Frederik J G M VanKuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-11       Impact factor: 4.799

Review 3.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Responses of cultured human keratocytes and myofibroblasts to ethyl pyruvate: a microarray analysis of gene expression.

Authors:  Stephen A K Harvey; Emily Guerriero; Nahthai Charukamnoetkanok; Jordan Piluek; Joel S Schuman; Nirmala Sundarraj
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

5.  Ethyl pyruvate ameliorates endotoxin-induced corneal inflammation.

Authors:  Divya Gupta; Yiqin Du; Jordan Piluek; Adam M Jakub; Kristine Ann Buela; Akshar Abbott; Joel S Schuman; Nirmala SundarRaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

6.  HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells.

Authors:  Guomin Jiang; Deming Sun; Huan Yang; Qingxian Lu; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2013-12-27       Impact factor: 4.962

7.  Ethyl pyruvate treatment mitigates oxidative stress damage in cultured trabecular meshwork cells.

Authors:  Amin Famili; David A Ammar; Malik Y Kahook
Journal:  Mol Vis       Date:  2013-06-11       Impact factor: 2.367

Review 8.  Nrf2, a Potential Therapeutic Target against Oxidative Stress in Corneal Diseases.

Authors:  Xiu-Fen Liu; Dan-Dan Zhou; Tian Xie; Tayyab Hamid Malik; Cheng-Bo Lu; Hai-Jun Li; Fan Wang; Chang Shu; Cong Liu; Cheng-Wei Lu; Ji-Long Hao
Journal:  Oxid Med Cell Longev       Date:  2017-10-25       Impact factor: 6.543

9.  Protective effect of ethyl pyruvate on epididymal sperm characteristics, oxidative stress and testosterone level in methotrexate treated mice.

Authors:  Elham Atashfaraz; Farah Farokhi; Gholamreza Najafi
Journal:  J Reprod Infertil       Date:  2013-10

Review 10.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.